Merck KGaA’s artificial intelligence software for drug discovery is finding its way to Indian start-ups with the company’s process solutions vertical extending a helping hand.
Merck KGaA, Aragen Execs On AI-Led Drug Discovery, Incubator Set-up, US Tariffs And More
Goldman Sachs Investee Seeks Further Funding
Merck’s India head for process solutions and Aragen Bioscience’s CEO talk about an incubator set-up and AI-led drug discovery to enable India’s research ecosystem, US tariffs on China, ADC and GLP-1 development, funding path for Goldman Sachs-investee Aragen and more in this video interview
